Treatment Of Metabolic Disorders In Canine Animals

Patent No. EP3485890 (titled "Treatment Of Metabolic Disorders In Canine Animals") was filed by Boehringer Ingelheim on Jan 20, 2015. The application was issued on May 10, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
CEVA SANTE ANIMALEFeb 9, 2024CABINET BECKER ASSOCIES
CEVA SANTE ANIMALEFeb 9, 2024CABINET BECKER ET ASSOCIES

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3485890

BOEHRINGER INGELHEIM
Application Number
EP18208143A
Filing Date
Jan 20, 2015
Status
Revoked
Sep 5, 2025
Publication Date
May 10, 2023